Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Transcell Oncologics is a private Hyderabad-based biotechnology company focused on stem cell research, oncology drug discovery, and human cell-based preclinical testing systems. The company appears to use adult stem cell and progenitor cell technologies to discover first-in-class anti-cancer molecules and to build in vitro human surrogate platforms as alternatives to animal testing. Its offerings include the Transtoxbio testing portfolio, the Biobox platform, and HEMATO stem-cell-based solutions for hematology and oncology use cases. Publicly available information suggests the business combines platform services with an internal therapeutic ambition in cancer and selected regenerative medicine applications, but its disclosed clinical pipeline remains limited. The company is associated with the University of Hyderabad's ASPIRE incubator ecosystem and has reported angel backing from Indian Angel Network.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Transcell Oncologies.